These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 26954320

  • 1. Effectiveness of Subcutaneous Methotrexate in Chronic Plaque Psoriasis.
    Yesudian PD, Leman J, Balasubramaniam P, Macfarlane AW, Al-Niaimi F, Griffiths CE, Burden AD, Warren RB.
    J Drugs Dermatol; 2016 Mar; 15(3):345-9. PubMed ID: 26954320
    [Abstract] [Full Text] [Related]

  • 2. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M, Chladek J, Simkova M, Vaneckova J, Grim J, Martinkova J.
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetic profile of methotrexate in psoriatic skin via the oral or subcutaneous route using dermal microdialysis showing higher methotrexate bioavailability in psoriasis plaques than in non-lesional skin.
    Quist SR, Quist J, Birkenmaier J, Stauch T, Gollnick HP.
    J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1537-43. PubMed ID: 27005005
    [Abstract] [Full Text] [Related]

  • 4. Analysis of factors influencing target PASI responses and side effects of methotrexate monotherapy in plaque psoriasis: a multicenter study of 1521 patients.
    Erduran F, Emre S, Hayran Y, Adışen E, Polat AK, Üstüner P, Öztürkcan S, Öztürk P, Ermertcan AT, Selçuk LB, Aksu EK, Akbaş A, Kalkan G, Demirseren D, Kartal SP, Topkarcı Z, Kılıç A, Yaldız M, Aytekin S, Hızlı P, Gharehdaghi S, Borlu M, Işık L, Botsalı BR, Solak EÖ, Albayrak H, Gönülal M, Balcı DD, Polat M, Daye M, Ataseven A, Yıldız S, Özer İ, Zorlu Ö, Doğan S, Erdemir VA, Dikicier BS.
    Arch Dermatol Res; 2024 May 25; 316(6):278. PubMed ID: 38796658
    [Abstract] [Full Text] [Related]

  • 5. Subcutaneous administration of methotrexate with a prefilled autoinjector pen results in a higher relative bioavailability compared with oral administration of methotrexate.
    Pichlmeier U, Heuer KU.
    Clin Exp Rheumatol; 2014 May 25; 32(4):563-71. PubMed ID: 24983446
    [Abstract] [Full Text] [Related]

  • 6. Weekly vs. daily administration of oral methotrexate (MTX) for generalized plaque psoriasis: a randomized controlled clinical trial.
    Radmanesh M, Rafiei B, Moosavi ZB, Sina N.
    Int J Dermatol; 2011 Oct 25; 50(10):1291-3. PubMed ID: 21950300
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of systemic methotrexate in two fixed doses of 10 mg or 25 mg orally once weekly in adult patients with severe plaque-type psoriasis: a prospective, randomized, double-blind, dose-ranging study.
    Dogra S, Krishna V, Kanwar AJ.
    Clin Exp Dermatol; 2012 Oct 25; 37(7):729-34. PubMed ID: 22830389
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial.
    Braun J, Kästner P, Flaxenberg P, Währisch J, Hanke P, Demary W, von Hinüber U, Rockwitz K, Heitz W, Pichlmeier U, Guimbal-Schmolck C, Brandt A, MC-MTX.6/RH Study Group.
    Arthritis Rheum; 2008 Jan 25; 58(1):73-81. PubMed ID: 18163521
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1).
    Barker J, Hoffmann M, Wozel G, Ortonne JP, Zheng H, van Hoogstraten H, Reich K.
    Br J Dermatol; 2011 Nov 25; 165(5):1109-17. PubMed ID: 21910713
    [Abstract] [Full Text] [Related]

  • 10. Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses ≥15 mg may be overcome with subcutaneous administration.
    Schiff MH, Jaffe JS, Freundlich B.
    Ann Rheum Dis; 2014 Aug 25; 73(8):1549-51. PubMed ID: 24728329
    [Abstract] [Full Text] [Related]

  • 11. The role of subcutaneous administration of methotrexate in children with juvenile idiopathic arthritis who have failed oral methotrexate.
    Alsufyani K, Ortiz-Alvarez O, Cabral DA, Tucker LB, Petty RE, Malleson PN.
    J Rheumatol; 2004 Jan 25; 31(1):179-82. PubMed ID: 14705239
    [Abstract] [Full Text] [Related]

  • 12. Utilization of Subcutaneous Methotrexate in Rheumatoid Arthritis Patients After Failure or Intolerance to Oral Methotrexate: A Multicenter Cohort Study.
    Branco JC, Barcelos A, de Araújo FP, Sequeira G, Cunha I, Patto JV, Oliveira M, Mateus MP, Couto M, Nero P, Pinto P, Monteiro P, Castelão W, Félix J, Ferreira D, Almeida J, Silva MJ.
    Adv Ther; 2016 Jan 25; 33(1):46-57. PubMed ID: 26724937
    [Abstract] [Full Text] [Related]

  • 13. Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis.
    Hoekstra M, Haagsma C, Neef C, Proost J, Knuif A, van de Laar M.
    J Rheumatol; 2004 Apr 25; 31(4):645-8. PubMed ID: 15088287
    [Abstract] [Full Text] [Related]

  • 14. The effect of folic acid supplementation on the pharmacokinetics and pharmacodynamics of oral methotrexate during the remission-induction period of treatment for moderate-to-severe plaque psoriasis.
    Chládek J, Simková M, Vanecková J, Hroch M, Chládkova J, Martínková J, Vávrová J, Beránek M.
    Eur J Clin Pharmacol; 2008 Apr 25; 64(4):347-55. PubMed ID: 18163165
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.
    Müller RB, von Kempis J, Haile SR, Schiff MH.
    Semin Arthritis Rheum; 2015 Aug 25; 45(1):28-34. PubMed ID: 25895697
    [Abstract] [Full Text] [Related]

  • 16. Retrospective evaluation of continuation rates following a switch to subcutaneous methotrexate in rheumatoid arthritis patients failing to respond to or tolerate oral methotrexate: the MENTOR study.
    Scott DG, Claydon P, Ellis C.
    Scand J Rheumatol; 2014 Aug 25; 43(6):470-6. PubMed ID: 24898259
    [Abstract] [Full Text] [Related]

  • 17. Methotrexate as a single agent for treating pulmonary sarcoidosis: a single centre real-life prospective study.
    Goljan-Geremek A, Bednarek M, Franczuk M, Puścińska E, Nowiński A, Czystowska M, Kamiński D, Korzybski D, Stokłosa A, Kowalska A, Wojda E, Sliwiński P, Burakowska B, Ptak J, Barańska I, Drygalska A, Małek G, Bestry I, Wesołowski S, Kram M, Górecka D.
    Pneumonol Alergol Pol; 2014 Aug 25; 82(6):518-33. PubMed ID: 25339562
    [Abstract] [Full Text] [Related]

  • 18. Methotrexate efficacy, but not its intolerance, is associated with the dose and route of administration.
    Fráňová J, Fingerhutová Š, Kobrová K, Srp R, Němcová D, Hoza J, Uher M, Saifridová M, Linková L, Doležalová P.
    Pediatr Rheumatol Online J; 2016 Jun 14; 14(1):36. PubMed ID: 27301536
    [Abstract] [Full Text] [Related]

  • 19. Subcutaneous methotrexate versus oral form for the treatment and prophylaxis of chronic plaque psoriasis.
    Attwa EM, Elkot RA, Abdelshafey AS, Hafez AR.
    Dermatol Ther; 2019 Sep 14; 32(5):e13051. PubMed ID: 31381231
    [Abstract] [Full Text] [Related]

  • 20. Comparative study of the effect of narrowband ultraviolet B phototherapy plus methotrexate vs. narrowband ultraviolet B alone and methotrexate alone in the treatment of plaque-type psoriasis.
    Al-Hamamy HR, Al-Mashhadani SA, Mustafa IN.
    Int J Dermatol; 2014 Dec 14; 53(12):1531-5. PubMed ID: 24738793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.